Amerant Bancorp Inc. (AMTB) — Current Report

AI-Powered SEC Filing Analysis

Latest Current Report Filed: 2026-04-10

Key Insights

Amerant Bancorp's director Pamella J. Dana will not seek re-election at the upcoming 2026 Annual Meeting of Shareholders, reducing the board size from 12 to 11 directors.
The departure of Dr. Dana is not due to any disagreement with the company's operations, policies, or practices, suggesting an amicable transition.
The reduction in board size may signal potential changes in the company's leadership or strategic direction going forward.

Want the newest filings?

This analysis covers the filing from 2026-04-10. New 10-K, 10-Q and 8-K filings are analyzed the moment they are released — exclusively in the app.

Download on the App Store Open in app →

Earlier Current Report filings

Filed: 2026-02-11

Amerant Bancorp Inc. (AMTB) filed an 8-K report on February 11, 2026 that indicates the company will be presenting an investor presentation on February 12, 2026.
The presentation appears to be intended for existing and prospective investors, suggesting the company may be seeking additional funding or making strategic announcements.
As an 8-K filing, this report discloses material events or corporate changes, which could have a significant impact on the company's operations and stock performance.

Filed: 2026-01-22

Amerant Bancorp reported strong financial results for the fiscal quarter and year ended December 31, 2025, indicating continued growth and profitability.
The company announced a cash dividend of $0.09 per share of its Class A common stock, signaling confidence in its financial position.
The board authorized a new $40 million share repurchase program, which could enhance shareholder value through capital return.

Filed: 2026-01-07

Amerant Bancorp Inc. has entered into an asset sale agreement with Peachtree Group to sell up to five loans with an estimated outstanding principal balance of $74.0 million as of December 31, 2025.
The company has closed the sale of three of the five loans for a total purchase price of approximately $49.7 million, with the purchaser exercising the right not to purchase the remaining two loans.
The asset sale agreement contains customary representations, warranties, covenants, and indemnification provisions, as well as standard closing conditions.

Filed: 2025-12-31

Amerant Bancorp has provided an update on its credit and asset quality, which could indicate changes in the company's financial health and risk profile.
The slide presentation attached to the 8-K filing suggests the company is proactively addressing potential credit or asset quality issues.
Investors should review the slide presentation for more details on the specific credit and asset quality updates to assess the company's overall performance and outlook.

Other reports for Amerant Bancorp Inc.

Quarterly Report Insider Trading

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.